SCHEMBL1313344

SCHEMBL1313344

CC(=O)c1cnc(-c2ccccn2)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 1.00
NPC1 O15118 7/20 0.63
RAB9A P51151 7/20 0.63
SMN1; SMN2 Q16637 4/20 0.63
MAPT P10636 4/20 0.63
POLB P06746 1/20 0.51
KDM4E B2RXH2 7/20 0.50
KMT2A Q03164 1/20 0.49
ATM Q13315 1/20 0.49
GAA P10253 1/20 0.47
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2160017 0.85 ALDH1A1 (0.74) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL2161303 0.84 ALDH1A1 (0.73) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL30664409 0.84 ALDH1A1 (0.72) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL6609203 0.84 ALDH1A1 (0.72) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL13285497 0.84 ALDH1A1 (0.72) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8284425 0.83 ALDH1A1 (0.70) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL6508481 0.81 ALDH1A1 (0.68) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL29670209 0.81 ALDH1A1 (0.68) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3593014 0.81 ALDH1A1 (0.68) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL850828 0.78 NPC1 (0.68) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 US disclosed
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 US disclosed
US-8809538-B2 Piperidine-containing compounds and use thereof ARRAY BIOPHARMA INC. (US) 2014-08-19 US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 US disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 US disclosed
EP-2375899-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF Array Biopharma, Inc. (US) 2011-10-19 EP disclosed
WO-2010080864-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF NOS1, NOS2, ASS1 ALDH1A1 28/4885NPC1 126/4885RAB9A 2811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.